a possible treatment for malignant melanoma

Herpes simplex virus HSV1716 replicates in and kills melanoma tumour cells, suggesting a possible therapeutic use.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Malignant melanoma, the most serious form of skin cancer, is composed of cells derived from the foetal neural crests. Herpes simplex virus (HSV) is neurotropic virus and can therefore localise in melanoma cells. HSV variant 1716 replicates preferentially in human melanoma cell lines in vitro, causing cell lysis and death. On the basis of this mechanism, researchers from University of Glasgow suggest in a research letter to the Lancet, that HSV1716 could be used for the local treatment of human malignant melanoma.

In a preliminary study, Rona MacKie and colleagues tested the effects of intratumoral injection of HSV1716 into subcutaneous nodules of metastatic melanoma in five patients with advanced (stage 4) disease. For each patient, a test nodule was injected with103 pfu HSV1716, and a second nodule was injected with 1 ml sterile saline as a control. In one patient, flattening of previously palpable tumour nodules was seen 21 days ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Tudor Toma

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio